Investors ignored the worst GDP report since the Great Recession and pinned their hopes on the positive news from Gilead (GILD) for a potential COVID-19 treatment.
Sign up to access the rest of this content!
This content is not available to free users. Sign up for a paid account to access the rest of this content.
